SCICLONE PHARMACEUT (NASDAQ:SCLN)
2.66
0.12 (4.32%)
| SCICLONE PHARMACEUT (NASDAQ:SCLN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $5.33 | ||
| Open | $2.76 | 52 Week Low | $0.63 | ||
| Day High | $2.78 | P/E | 20.46 | ||
| Day Low | $2.64 | EPS | $0.13 | ||
| Volume | 198,379 | ||||
| More SCLN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| AMRI | 3 | AVII | 3 |
| REED | 2 | APEI | 2 |
| SGEN | 2 | DVAX | 2 |
| MBI | 2 | CMLS | 2 |
| MR | 2 | TNS | 2 |
| CRXX | 2 | DEPO | 2 |
Entities who have mentioned SCLN
- Merriman Curhan Ford | View Related Stories »
- JPMorgan | View Related Stories »
- Needham & Co | View Related Stories »
- Lazard | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Morgan Stanley | View Related Stories »
- After-Hours Movers | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Wedbush Morgan | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Layoffs | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- ThinkEquity | View Related Stories »
- BWS Financial | View Related Stories »
- William Blair | View Related Stories »
- Citi | View Related Stories »
- Deutsche Bank | View Related Stories »
View All Major News StreetInsider.com Major News for SCLN
- SciClone Pharmaceuticals (SCLN) Lower After Discontinuing Phase 2 Trial of RP101
- SciClone Pharma (SCLN) Swings to Q2 Profit; Guides FY09 Above the Street
- SciClone Pharma (SCLN) Reports Breakeven Q1 Earnings; Guides FY09
View All ReportsStreetInsider.com Reports on SCLN
- National Securities Initiates Coverage on SciClone Pharmaceuticals (SCLN) with a Buy
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- SciClone Pharma (SCLN) to Reduce US Based Workforce Approximately 17%
- Unusual 11 Mid-Day Movers 10/05: ROIAK, DEPO, AVII, CMLS Higher; FOLD, SGEN, SCLN, REED Lower
- Morning Movers 10/05: DEPO, AVII, OPTV, CRXX, UCTT, CPRX Higher; FOLD, FTBK, SGEN, SCLN, REED Lower
View All Press ReleasesCompany Press Releases on SCLN
- SciClone Pharmaceuticals Announces Presentations of SCV-07 Data at Upcoming Medical Meetings
- SciClone Reports Financial Results and Provides Commercial and Pipeline Updates for the Third Quarter of 2009
- SciClone Pharmaceuticals to Present at Two November Investor Conferences
- SciClone Pharmaceuticals to Report Third Quarter 2009 Results on November 9
- SciClone Announces Enrollment of First Patient in Its Phase 2 Trial of SCV-07 in Hepatitis C
StreetInsider Reports on SCLN by Category
View All BlogsBlogs on SCLN
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
- Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
- Closing Update for Wednesday, August 5
- Breakout Stocks on Huge Volume: Three Option Trades
- Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
View All FilingsSEC Filings on SCLN
- Form 10-Q SCICLONE PHARMACEUTICALS For: Sep 30
- Form 8-K SCICLONE PHARMACEUTICALS For: Nov 09
- Form 8-K SCICLONE PHARMACEUTICALS For: Nov 05
- Form 8-K SCICLONE PHARMACEUTICALS For: Oct 28
- Form 8-K SCICLONE PHARMACEUTICALS For: Oct 02
Comments on recent SCLN articles
Comments on SCLN
No comments are currently available.
on Jun 4, 2009
at 07:27 AM SCLN It's about time!!!!!!!!
Article: ThinkEquity Initiates Coverage on SciClone (SCLN) with a Buy